12th Annual Lung Cancer Symposium

Thursday, March 7, 2024, 7:00 AM - Friday, March 8, 2024, 5:00 PM, The Warwick Hotel - 220 S 17th St, Philadelphia, PA


AMA PRA Category 1 Credits™ (14.25 hours), Non-Physician Attendance (14.25 hours), ANCC Contact Hour(s) (14.25 hours), AAPA Category 1 CME Credits (14.25 hours), Nursing Pharmacology Credit (6.75 hours), PA Patient Safety and Risk Credit (5.25 hours)

The 12th Annual Lung Cancer Symposium offers physicians, nurses, physician assistants, respiratory care specialists and public health professionals a comprehensive lung cancer update, and provide an interdisciplinary perspective of the disease, care and treatment management plans.

1. Discuss new modalities of surgery which can lead to long-term cures and optimal results for patients with lung cancer.
2. Examine the utilization of a multidisciplinary team in the treatment of lung cancer.
3. Assess the evolving radiotherapy techniques in treatment of lung cancer.
4. Review the newest targeted molecular therapies and immunotherapies for lung cancer.
5. Explain state of the art of lung cancer prevention.
6. Evaluate the most appropriate diagnostic approach for lung nodules, lung masses, and metastatic lesions.
7. Recognize how treatment techniques vary based on lung cancer disease stage.
8. Assess the use of SBRT in early stage lung cancer treatment.
9. Identify specific strategies to implement on lung cancer disease management as part of a continuing improvement process for clinical practices.
10. Employ lung cancer screening best practices for collaboration with multi-disciplinary teams to improve patient care.
11. Assess respiratory care treatment strategies for lung cancer patients.
12. Employ the latest community outreach strategies to reduce lung cancer disparities around the region.
13. Explain the role of sub lobar versus lobar resection in treating lung cancer with surgical intervention.
14. Identify patients that are ideal candidates for minimally invasive, robotic surgery as a treatment for early stage lung cancer.
15. Examine the role of pulmonary rehabilitation with lung cancer patients.
16. Practice multi-disciplinary collaboration with thoracic surgery, medical oncology, radiation oncology, and interventional pulmonology through a mock tumor board.
17. Apply relationship-building values and the principles of collaboration in caring for lung cancer patients.
18. Evaluate the latest cutting-edge robotic bronchoscopy modalities.
19. Assess tobacco cessation strategies in a respiratory care context.
20. Compare evolving immunotherapy modalities for genetic mutations in lung cancer treatment.

Registration Rates:
- Physicians - $249
- Nurse, Nurse Practitioner, Allied Health Professionals- $145
- Social Worker - $100
- Non-Jefferson Residents/ Fellows - $100
- Sidney Kimmel Cancer Network Member - $100
- Jefferson Health Faculty and Staff - $0
- Industry - $400

Important Deadlines
- Pre-registration ends Tuesday, March 5, 2024
- Onsite/ Day of registrations will be accepted
- No refunds will be granted after February 22, 2024. See full refund policy.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 14.25 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 14.25 nursing contact hours.

Physicians Assistants:

 

Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Other Healthcare Professionals: This educational activity is designated for 14.25 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
Nursing Pharmacology Credit: This educational activity offers 6.75 nursing pharmacology credit. Qualifying sessions are noted on the agenda.

PA Patient Safety and Risk Credit: This education activity offers 5.25 PA Patient Safety and Risk credit. Qualifying sessions are noted on the agenda.

Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than <Date-20 days after the last date of activity>. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Cancellation Policy

Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

Submit refund requests to: Office of Continuing Professional Development Sidney Kimmel Medical College Jefferson Alumni Hall 1020 Locust Street, Suite M-5 Philadelphia, PA 19107

Or by email to [email protected] - please include the activity name in the subject line.

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

The Warwick Hotel Rittenhouse Square Philadelphia

 220 S 17th St, Philadelphia, PA 19103

 

Parking rates*:

• $26/ Day
• $49/Overnight
• $59/ Valet
  

* Subject to change

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Exhibit opportunities are available for this conference. For more information, please contact Ariel Levine at [email protected].